News | June 14, 2026
India clears major milestone in cervical cancer fight with validation of first indigenous HPV DNA test
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Approval is based on results from the phase 3 OASIS 4 clinical trial
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
The Prayagraj lab is designed to handle both routine and specialised testing
The award places the company in the top 5% globally
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
Subscribe To Our Newsletter & Stay Updated
